18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety

Clinical trial NCT03042416 · COMPLETED

Trial details

NCT number: NCT03042416
Sponsor: University of Alberta
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Hyperinsulinism Neuroblastoma Neuroendocrine Tumors Parkinson Disease Brain Glioma

Start date: 2017-06-29
Primary completion: 2021-03-05
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.